Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CAP, adenylate cyclase-associated protein 1 pseudogene 1 (CAP1P1)
- Target
- CAP1P1
- Molecular classification
- Pseudogene, Other
01
Overview
CAP1P1 is a pseudogene version of the cyclase-associated actin cytoskeleton regulatory protein 1 (CAP1). Unlike the functional CAP1, which regulates actin filament dynamics and is involved in nervous system development and some cancers[2], CAP1P1 does not encode a functional protein. Pseudogenes arise from duplication or retrotransposition events and contain disruptive mutations that prevent protein coding. While some pseudogenes can affect gene regulation or act as competitive endogenous RNAs, CAP1P1 has not been clearly linked to such biological functions nor to any disease role[3]. Summary: CAP1P1 is a non-coding pseudogene with no direct therapeutic relevance, biomarker status, or documented biological or disease function as of current knowledge[3].
- Other names
- CAP1 pseudogene 1CAP, adenylate cyclase-associated protein 1 pseudogeneCAP1P1
02
Biological functions
Other — While pseudogenes may occasionally participate in regulatory functions such as acting as miRNA decoys or influencing their parental gene’s expression, CAP1P1 specifically has not been described with such a function[3].
03
Disease associations
Other — Some pseudogenes are implicated in cancer or other diseases by regulating gene expression, but no direct involvement of CAP1P1 has been documented[3].
Beyond the preview
Go deeper on CAP, adenylate cyclase-associated protein 1 pseudogene 1 (CAP1P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CAP, adenylate cyclase-associated protein 1 pseudogene 1 (CAP1P1).